The high expression rates of HHLA2 in the two independent ICC cohorts were 49.0 and 67.7% respectively, which was on a medium to high end of the expression spectrum, higher than previous data on gall bladder cancers (0/10) and liver cancers (4/10) [17]. Here, HHLA2 is linked to gallbladder cancer.